Phenytoin is an established therapy for post-herpetic neuralgia. In order to maintain serum phenytoin levels in the normal therapeutic range, serum phenytoin monitoring is required. This range may, however, be misleading in certain clinical conditions. We report here a patient with hypoalbuminaemia who developed marked clinical phenytoin toxicity despite maintenance of the serum total phenytoin concentration within the therapeutic range.
TaubA.Management of post-herpetic neuralgia. Drug therapy1984; 14: 191–6.
2.
HatangdiVSBoasRARichardsEG. Post-herpetic neuralgia: Management with anti-epileptic and tricyclic drugs. In: BonicaJJAlbe-FessardD. Advances in Pain Research and Therapy Vol. New York, Raven Press1976. pp 583–7.
3.
TozerTNWinterME. Phenytoin. In: EvansWESchentagJJJuskoWJ. Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. San Francisco: Applied Therapeutics1980. pp 275–314.
